The India skin boosters market was valued at USD 21.66 million in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2030. A key factor driving this growth is the increasing acceptance and popularity of skin boosters in the Indian aesthetic treatment landscape. Although a relatively new concept, skin boosters have gained substantial traction in recent years as more individuals seek minimally invasive solutions for skin enhancement. These injectables are designed to deliver hyaluronic acid (HA) deep into the skin, improving hydration, elasticity, and texture—making them a favored option for natural-looking skin rejuvenation.

To keep pace with rising demand and remain competitive, companies are heavily investing in research and development (R&D) to introduce next-generation skin boosters that offer enhanced efficacy, safety, and comfort. This competitive market environment is pushing innovation, leading to the development of advanced formulations and improved delivery systems.

In addition to R&D efforts, major industry players are expanding production capacities and setting up new manufacturing facilities to support broader market reach and customer base expansion. For example, in April 2023, Merz Pharma announced the construction of a new manufacturing facility in Reinheim, located in Germany’s Odenwald region. This facility aims to boost the company’s production capabilities and streamline its manufacturing processes to better meet global and regional demands.

Skin boosters are increasingly preferred in the Indian market because they offer noticeable improvements in skin hydration and texture without the typical downtime or adverse effects often associated with traditional dermal fillers, laser resurfacing, or chemical peels. With minimal side effects such as bruising or swelling, these treatments are ideal for consumers seeking non-invasive options for aesthetic enhancement, further contributing to their growing popularity in India’s booming cosmetic dermatology space.

Key Market Trends & Insights:

• Based on type, the mesotherapy segment emerged as the dominant category in the India skin boosters market, accounting for the largest revenue share of 54.4% in 2023. This reflects the strong preference for mesotherapy treatments, which involve microinjections of skin-nourishing substances such as hyaluronic acid, vitamins, and enzymes directly into the skin. The growing demand for non-surgical, minimally invasive procedures that offer visible results in skin hydration and rejuvenation has significantly contributed to the widespread adoption of mesotherapy-based skin boosters.

• Based on gender, the female segment captured the largest share of market revenue at 85.4% in 2023, underscoring the high demand for aesthetic treatments among women in India. This trend is driven by increasing awareness of skincare, social media influence, and a rising inclination among women to invest in advanced cosmetic procedures that promote youthful, glowing skin. The significant female participation in aesthetic treatments continues to propel market growth and shape product development and marketing strategies.

• Based on end-use, the medical spa segment led the market, holding the largest revenue share of 64.5% in 2023. This dominance highlights the growing popularity of medical spas as preferred destinations for aesthetic treatments, offering a blend of medical expertise and a spa-like environment. Medical spas are increasingly equipped with trained professionals and advanced technologies, making them ideal settings for safe and effective administration of skin booster treatments. Their widespread presence and customer-centric approach contribute to their leading position in the market.

Order a free sample PDF of the India Skin Boosters Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2023 Market Size: USD 21.66 Million

• 2030 Projected Market Size: USD 43.02 Million

• CAGR (2024-2030): 10.5%

Key Companies & Market Share Insights:

Some of the key players operating in the India skin boosters market include Merz Pharma and Galderma, among others.

• Merz Pharma, through its skincare division Merz Aesthetics GmbH & Co KG, focuses on the development and commercialization of advanced aesthetic treatments targeting a variety of skin concerns such as wrinkles, fine lines, acne scars, and skin laxity. The division’s product range includes injectable fillers and other non-surgical skin-lifting and tightening solutions designed to deliver effective, minimally invasive results. Merz Aesthetics places a strong emphasis on research and development, continually striving to bring forward innovative aesthetic solutions that produce natural-looking outcomes for patients both in India and across the global market.

• Galderma, a Swiss multinational pharmaceutical company, specializes in dermatological treatments for both medical and aesthetic skin conditions. Its comprehensive product portfolio includes prescription medications for a wide range of skin issues, including acne, psoriasis, rosacea, vitiligo, actinic keratosis (a pre-cancerous skin condition), and certain types of skin cancer. Galderma is committed to advancing dermatological science through continuous medical research and collaborations with academic institutions and industry leaders, aiming to deliver innovative and effective skin treatments globally.

Other notable participants in the global skin boosters market with operations or presence in India include AbbVie Inc., Medytox India, Sinclair Pharma, and Allergan India.

• Medytox India, a subsidiary of Medytox Inc.—a South Korean biopharmaceutical company—specializes in aesthetic neurotoxin products. The company provides a variety of skin boosters, including formulations like Medytox BTX-A, which are used in aesthetic medicine for skin rejuvenation and wrinkle treatment.

• Sinclair Pharma, a UK-based aesthetics company, operates in the Indian market through its local division, Sinclair Pharma India. The company markets a range of skin booster products under the brand name Juvederm, which are widely used in non-invasive aesthetic procedures to enhance skin quality, volume, and elasticity.

Key Players

• Medytox, Inc.

• AbbVie Inc.

• Merz Pharma

• Galderma

• Teoxane

• IBSA Farmaceutici Italia Srl

• PharmaResearch Co., Ltd

• Sinclair Pharma

• Allergan India

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The India skin boosters market is experiencing significant growth, driven by increasing consumer demand for non-invasive aesthetic treatments. Key factors contributing to this expansion include a rising number of beauty clinics and medical spas, a rapidly aging population, higher disposable incomes, and the influence of celebrity culture promoting skincare awareness. Regulatory bodies like the Central Drugs Standard Control Organization (CDSCO) have implemented stringent guidelines to ensure the safety and efficacy of skin booster products, thereby enhancing consumer trust. Leading companies are investing in research and development to introduce innovative formulations and expanding their production capabilities to meet the growing market demand. These developments are expected to further propel the market's growth trajectory in the coming years.